All news

Additional AUD$10 million will support MMV’s mission over the next 3 years 

24 March 2015

Malaria endemic-country researchers among recipients of grants to boost neglected disease drug research

06 March 2015

US$637,000 to support quest to stay ahead of emerging malaria drug resistance 

05 February 2015

Combination could be the long-sought single-dose cure for malaria

20 January 2015

Dr Simon Campbell, CBE FRS, receives Queen’s honour for services to chemistry

12 January 2015

Most vulnerable populations remain the hardest hit

10 December 2014

MMV and partners build a strong portfolio of new PfATP4 inhibitors in translational medicine ready for clinical development

09 December 2014

Collaborations set to advance life-saving pre-referral treatment for severe malaria

27 November 2014

RBM seeks input for the second Global Malaria Action Plan

20 November 2014

Coartem® Dispersible was developed by Novartis and MMV to change the way children with malaria are treated

19 November 2014